Dr.ย Ranย Loewenthal
MD (Doctor of Medicine)
Professor of Medical Oncology | Head, Oncology
corporate_fareWolfson Medical Center, Holon, Israel
Ran Loewenthal
MD (Doctor of Medicine)
Prof. Ran Loewenthal, MD, is a senior medical oncologist at Wolfson Medical Center in Holon, Israel, with over 20 years of clinical experience in treating solid tumours. He holds an academic appointment connected with Tel Aviv University and leads the oncology department at Wolfson, one of the major multidisciplinary hospitals in central Israel.
Prof. Loewenthal's clinical practice centres on the systemic management of colorectal cancer, lung cancer, and breast cancer. His approach integrates chemotherapy, targeted therapy, and immunotherapy, guided by pathology findings, molecular biomarkers, and each patient's prior treatment history. He participates in a multidisciplinary tumour board model that brings together oncology, surgery, radiation, pathology, and radiology to plan coordinated cancer care. His profile is particularly relevant for patients who require a specialist opinion for advanced or metastatic disease, including second opinions on complex oncology cases. International patients from South Asia, the Middle East, Eastern Europe, and the CIS region have sought oncology consultations in Israel for colorectal, lung, and breast cancers.
Why Consider Prof. Ran Loewenthal?
Prof. Loewenthal is a senior oncologist in the Wolfson Medical Center network in central Israel, with over two decades of experience in the systemic treatment of colorectal, lung, and breast cancers.
Areas of Specialisation
Prof. Loewenthal focuses on systemic oncology for colorectal, lung, and breast cancers, including advanced and metastatic presentations.
Prof. Ran Loewenthal's specialisation covers medical oncology for solid tumours, with particular depth in colorectal cancer, lung cancer, and breast cancer. Treatment planning is evidence-based and guided by tumour biology, molecular markers, and each patient's individual clinical context.
Colorectal Cancer
Systemic treatment planning for colon and rectal cancers, including metastatic and recurrent disease.
- arrow_rightFOLFOX, FOLFIRI, and CAPOX-based protocols
- arrow_rightAdjuvant chemotherapy after surgery for eligible patients
- arrow_rightPalliative chemotherapy for metastatic colorectal cancer
- arrow_rightBevacizumab and anti-VEGF therapy for selected patients
- arrow_rightEGFR-targeted agents for RAS wild-type colorectal cancer
- arrow_rightImmunotherapy for MSI-high or dMMR colorectal cancer
Lung Cancer
Medical oncology management for non-small cell and small cell lung cancer, including advanced and metastatic presentations.
- arrow_rightEGFR, ALK, ROS1, BRAF, MET, RET, and KRAS G12C inhibitor selection
- arrow_rightBiomarker-driven treatment sequencing for NSCLC
- arrow_rightTreatment planning after progression on prior targeted agents
- arrow_rightPD-1 and PD-L1 checkpoint inhibitors for eligible patients
- arrow_rightCombination chemo-immunotherapy for advanced NSCLC
- arrow_rightPD-L1 expression assessment to guide therapy selection
Breast Cancer
Systemic therapy planning for hormone receptor-positive, HER2-positive, and triple-negative breast cancer, including metastatic disease.
- arrow_rightEndocrine therapy with CDK4/6 inhibitor combinations
- arrow_rightTreatment sequencing for ER-positive metastatic breast cancer
- arrow_rightChemotherapy evaluation for high-risk early-stage disease
- arrow_rightHER2-targeted therapy including trastuzumab-based regimens
- arrow_rightAntibody-drug conjugates for eligible patients
- arrow_rightImmunotherapy consideration for PD-L1-positive triple-negative breast cancer
Procedures & Clinical Services
Systemic treatment planning and oncology care at Wolfson Medical Center
Prof. Loewenthal provides medical oncology services across a range of solid tumours. His clinical services include treatment planning, systemic therapy administration oversight, biomarker review, and multidisciplinary coordination for colorectal, lung, and breast cancer patients.
Systemic Cancer Treatment
Medical OncologyComprehensive systemic therapy planning for colorectal, lung, and breast cancers, including first-line, second-line, and subsequent therapy selection.
Targeted Therapy Planning
Targeted TherapyPersonalised targeted treatment planning based on tumour molecular profile, mutation status, and biomarker testing.
Cancer Diagnosis Support
DiagnosisEvaluation of biopsy findings, molecular test interpretation, and staging review to guide treatment planning.
Second Opinion Consultations
Second OpinionExpert second opinion for patients with colorectal, lung, or breast cancer who wish to review their current diagnosis, staging, or treatment plan.
Research & Academic Affiliations
Academic connections and clinical research in medical oncology
Prof. Loewenthal holds an academic connection with Tel Aviv University and practises at Wolfson Medical Center, a hospital involved in clinical teaching and oncology research in the central Israel network.
A detailed publication list and specific research contributions will be added after verification with academic databases. Contact CancerFax for further information about Prof. Loewenthal's research profile.
Education & Training
Prof. Loewenthal completed his medical training in Israel, including a connection with Tel Aviv University. Full education timeline details are pending official source verification.
Clinical Experience
Prof. Ran Loewenthal has over 20 years of experience as a medical oncologist in Israel, practising at Wolfson Medical Center in Holon, one of the major multidisciplinary public hospitals in the central Israel region.
Languages & International
Prof. Ran Loewenthal consults in the following languages.
CancerFax can arrange professional medical interpreter support for international patients who require assistance in Arabic, Russian, Hindi, or other languages during the consultation process.
CancerFax can coordinate professional medical interpreter support for patients consulting in other languages.
How CancerFax Helps You Access Dr. Ran Loewenthal
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Ran Loewenthal's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Ran Loewenthal's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Ran Loewenthal before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Ran Loewenthal's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Ran Loewenthal's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Ran Loewenthal's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Ran Loewenthal
Prof. Ran Loewenthal, MD, is a senior medical oncologist and Head of Oncology at Wolfson Medical Center in Holon, Israel. With over 20 years of clinical experience, he specialises in the systemic treatment of colorectal cancer, lung cancer, and breast cancer, including advanced and metastatic presentations. He holds an academic connection with Tel Aviv University.
Prof. Loewenthal's primary clinical focus is colorectal cancer, lung cancer, and breast cancer. He treats patients across disease stages, including early, locally advanced, metastatic, and recurrent presentations. His practice also covers other solid tumours within the scope of medical oncology at Wolfson Medical Center.
Prof. Loewenthal's clinical services include chemotherapy, targeted therapy, and immunotherapy. Treatment planning is guided by pathology reports, molecular biomarker testing, tumour staging, and prior treatment history. He works within a multidisciplinary team that includes surgery, radiation oncology, pathology, and radiology specialists at Wolfson Medical Center.
Yes. International patients seeking an oncology consultation or second opinion for colorectal, lung, or breast cancer may request coordination support through CancerFax. CancerFax can help organise medical records, pathology reports, imaging summaries, and molecular test results for submission and consultation review, subject to hospital availability and case acceptance.
You can submit your medical reports through CancerFax. The CancerFax team will review your documents, prepare the case summary, and coordinate the next steps with Wolfson Medical Center, subject to availability. For assistance, visit CancerFax.com or contact the patient support team directly.
A second-opinion request can be coordinated through CancerFax. Patients should submit their histopathology report, immunohistochemistry findings, imaging reports, molecular test results, and a treatment summary. Prof. Loewenthal's team can review the case and provide an independent oncology opinion. The consultation format and availability depend on the hospital's scheduling and case-acceptance process.
Connect with Ran Loewenthal Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.